Please enter a search term below

Search results

1 results found Showing page 1 of 1

  • US loan trading: CLOs treated to DaVita as Refinitiv outflows escalate
    US CLO managers were treated to a $2.75 billion term loan B by kidney dialysis services provider DaVita, which became the most popular issuer in August. And Refinitiv US Holdings continued to be the most sold US issuer by CLOs, according to the latest trustee reports from CLO-i 

    4 years ago

1 results found Showing page 1 of 1

Want all the latest news, comment, analysis and data?

Register now Start a Free Trial